In the present study, we hypothesized that the combination of MIF and SCD1 is useful not only a diagnostic marker for discrimination between MFH and MFS, but also represents a prognostic marker for the overall outcome of STS. The gene discussed is MIF; the disease is undifferentiated pleomorphic sarcoma.